We've been making
headlines.

UPMC Partnership Expands Chronic Disease Medication Adherence Learn More

The need for dynamic pricing in healthcare Learn More

Sempre Health revamps Rx discounts with smart phone texts Learn More

UPMC, Sempre Health growing text message-based medication adherence program Learn More

Are digital therapeutics the new specialty pharma? Learn More

BCBSAZ Tackles Medication Adherence Through Mobile Health Learn More

Blues plans banking on Sempre Health’s gamified approach to slash medication costs Learn More

Building trust through technology for medication adherence Learn More

Digital Health Briefing mention Learn More

Digital therapeutics, medication adherence, clinical trials were key pharma interests in Q2 Learn More

Gamifying healthcare to reduce costs Sempre Health launches from the Alchemist Accelerator Learn More

How can human behavior help adherence? Learn More

How drugmakers are facing the entrance of consumer giants into healthcare Learn More

Medication adherence incentive platform Sempre Health raises $8M Learn More

Novo Nordisk collaborates with healthcare startup to incentivize diabetes medication adherence Learn More

Novo Nordisk partners to improve medicine costs for diabetics in USA Learn More

Novo Nordisk tackles outcomes and affordability with pilot tying copays to adherence Learn More

Novo Nordisk ties discounts to adherence in SMS pilot Learn More

Novo Nordisk, Sempre Health and other digital health deals Learn More

Novo Nordisk, Sempre Health Launch Pilot to Improve Medication Costs for Diabetic Patients Learn More

On a mission to lower the cost of prescription meds, Sempre Health raises $15M Learn More

Rewarding healthy behavior with lower medication costs, Sempre Health embarks on pilot with Pa insurer Learn More

Sempre Health and UPMC Health Plan Expand Program to Improve Adherence for Critical Medications Learn More

Sempre Health bags $8 mln Series A Learn More

Sempre Health is gamifying healthcare to reduce costs Learn More

Sempre Health Launches Behavior-based Healthcare Pricing Platform for Patients Learn More

Sempre Health Partners With Blue Cross Blue Shield Of Arizona To Help Members Save On Medications Learn More

Sempre Health Raises $8M for Behavior-based Healthcare Pricing Platform Learn More

Sempre Health Raises $8M in Series A Funding Learn More

Sempre Health Raises $8M Series A to Improve Access to Medications across the US Learn More

Sempre Health rakes in $8 million to improve patient behavior and medication adherence Learn More

Sempre Health teams up with Pennsylvania health plan to lower drug prices Learn More

Sempre Health uses discounts to encourage timely prescription refills Learn More

Startup offers lower prescription costs for undisclosed Pennsylvania health plan Learn More

Term Sheet — Wednesday, August 29 Learn More

The Friendly Ghost: July 23, 2017 Snippets Learn More

This Startup Just Raised $15 Million To Help People Better Afford Their Medicines Learn More

This startup wants to make drugs cheaper with “behavior-based” pricing Learn More

UPMC Health Plan expands program for prescription discounts Learn More

We got a look at the pitch deck of buzzy Silicon Valley health-tech startup Sempre Health. It reveals how a $4 billion industry is ripe for disruption. Learn More

PRESS

Press releases

Sempre Health Raises $15M in Series B Financing to Improve Medication Affordability

PR Newswire

Blue Cross Blue Shield of Arizona and Sempre Health Collaborate to Further Improve Medication Adherence and Affordability

PR Newswire

UPMC Health Plan Further Expands its Sempre Health Partnership to Better Serve Patients with Diabetes

GlobeNewsWire

Navitus Health Solutions Partners with Sempre Health to Help Members Save on and Adhere to Medications Through SMS Engagement

BusinessWire

Sempre Health Reports Record Growth of 450 Percent in Members Nationwide

PR Newswire

Sempre Health Honored By Goldman Sachs For Entrepreneurship

PR Newswire

1 2

We've been making headlines.

Press releases

Get in touch to discuss press

We've been making
headlines.

Get in touch to discuss
press